Physician profile
Stephen Lefler
NPI 1073554929
$1,020.63
in general payments reported to CMS, 2019-2025
18 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $50.65 · 2021: $40.97 · 2022: $254 · 2023: $209 · 2024: $44.31 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.20 | 2019-2022 | |
| Meditrina | $146.57 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.65 | 2019-2024 | |
| Daiichi Sankyo INC. | $95.76 | 2019 | |
| Pfizer INC. | $75.80 | 2019-2022 | |
| Astellas Pharma US INC | $54.61 | 2025 | Veozah |
| Exeltis, USA INC. | $51.31 | 2020-2024 | Slynd |
| Therapeuticsmd, INC. | $47.85 | 2020-2022 | |
| Davol INC. | $38.63 | 2022 | |
| Organon LLC | $31.97 | 2022-2023 | Nexplanon |
| Smith+Nephew, INC. | $28.73 | 2023 | Pico 7, Pico 14 |
| Biogen, INC. | $27.83 | 2025 | Zurzuvae |
| Allergan, INC. | $25.33 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $23.63 | 2022 | |
| Hologic Sales and Service, LLC | $20.71 | 2025 | Thinprep 2000 Processor, Aptima |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.69 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $18.00 | 2019 | |
| Amgen INC. | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lefler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.